Access to essential, life-saving medicines remains one of the most pressing global health challenges, particularly in low- and middle-income countries (LMICs). Despite advancements in global health, ...
Biosimilar adoption is hindered by complex reimbursement structures and misaligned incentives, despite their cost-saving potential. Collaborative stakeholder efforts and leveraging electronic health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback